Patrick D Walsh insider trades
Open-market stock purchases and sales by Patrick D Walsh, Director at ANI Pharmaceuticals Inc, from SEC Form 4 filings since Oct 20, 2017.
Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +158%.